Page last updated: 2024-08-17

adenosine monophosphate and Cytokine Release Syndrome

adenosine monophosphate has been researched along with Cytokine Release Syndrome in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	15 (100.00)	2.80

Authors

Authors	Studies
Ferrara, F; Vitiello, A	1
Anderson, C; Neil, GA; Perlin, DS; Raines, S; Ware, CF; Wilkins, HJ; Zafir-Lavie, I	1
Abu Bakar, U; Gan, SH; Jaber, AAS; Jusnita, N; Lukas, S; Pratiwy, I; Ramatillah, DL; Syed Sulaiman, SA	1
Drosos, AA; Pelechas, E; Voulgari, PV	1
Fang, Y; Meng, XM; Ni, WJ; Shen, AZ; Xu, T; Zhou, H	1
Jia, X; Kai, G; Li, L; Nile, A; Nile, SH; Qiu, J	1
Akinosoglou, K; Davoulos, C; Fligkou, F; Gogos, C; Kalogeropoulou, C; Marangos, M; Spyridonidis, A; Tousis, A; Tsiotsios, K; Velissaris, D; Ziazias, D	1
Magro, G	1
Bellutti-Enders, F; Hartmann, K; Jamiolkowski, D; Leuppi-Taegtmeyer, A; Manjaly Thomas, ZR; Scherer Hofmeier, K; Steveling-Klein, E	1
Ijaz, M; Khan, M; Kharaba, ZJ; Murtaza, G; Shamim, S	1
Gonzales-Zamora, JA; Quiroz, T; Vega, AD	1
Entezari-Maleki, T; Khiali, S; Rezagholizadeh, A	1
Ekobena, P; Ivanyuk, A; Livio, F	1
Dehghan, H; Fazlzadeh, A; Haddad, F; Kheirabadi, D; Mousavi-Roknabadi, RS; Rezaeisadrabadi, M	1
Afridi, M; Akhtar, H; Akhtar, S; Ali, S; Khader, YS; Khalid, S	1

Reviews

9 review(s) available for adenosine monophosphate and Cytokine Release Syndrome

Article	Year
Treatment strategies of COVID-19: A rheumatology perspective. European journal of internal medicine, 2022, Volume: 102 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Antibodies, Monoclonal; COVID-19 Drug Treatment; Critical Illness; Cytokine Release Syndrome; Cytokines; Humans; Rheumatology; SARS-CoV-2	2022
Potential therapeutic targets and promising drugs for combating SARS-CoV-2. British journal of pharmacology, 2020, Volume: 177, Issue:14 Topics: Adenosine Monophosphate; Alanine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antiviral Agents; Basigin; Benzamidines; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; COVID-19 Vaccines; Cytokine Release Syndrome; Esters; Gabexate; Genome, Viral; Guanidines; Humans; Immunization, Passive; Immunosuppressive Agents; Medicine, Chinese Traditional; Nucleic Acid Synthesis Inhibitors; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; Protease Inhibitors; RNA-Dependent RNA Polymerase; SARS-CoV-2; Serine Endopeptidases; Spike Glycoprotein, Coronavirus; Viral Vaccines; Virus Internalization; Virus Replication	2020
COVID-19: Pathogenesis, cytokine storm and therapeutic potential of interferons. Cytokine & growth factor reviews, 2020, Volume: 53 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Cytokines; Drug Therapy, Combination; Humans; Inflammation; Interferons; Oligonucleotides; Pandemics; Pneumonia, Viral; SARS-CoV-2; Viral Vaccines	2020
COVID-19: Review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking. Virus research, 2020, Volume: 286 Topics: Adenosine Monophosphate; Alanine; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Anticoagulants; Antiviral Agents; Azetidines; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Drug Combinations; Heparin; Humans; Hydroxychloroquine; Inflammation; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Purines; Pyrazoles; Ritonavir; SARS-CoV-2; Sulfonamides	2020
Emerging treatments in COVID-19: Adverse drug reactions including drug hypersensitivities. The Journal of allergy and clinical immunology, 2020, Volume: 146, Issue:4 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Drug Hypersensitivity; Humans; Immunity, Innate; Immunologic Factors; Indoles; Infliximab; Interleukin 1 Receptor Antagonist Protein; Nitriles; Pandemics; Pneumonia, Viral; Pyrazines; Pyrazoles; Pyrimidines; SARS-CoV-2; Severity of Illness Index	2020
Potential strategies for combating COVID-19. Archives of virology, 2020, Volume: 165, Issue:11 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Alanine; Amides; Antibodies, Monoclonal, Humanized; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Serotherapy; COVID-19 Vaccines; Cytokine Release Syndrome; Drug Combinations; Humans; Hydroxychloroquine; Immunization, Passive; Immunologic Factors; Indoles; Interleukin 1 Receptor Antagonist Protein; Lopinavir; Pandemics; Pneumonia, Viral; Pyrazines; Ritonavir; SARS-CoV-2; Severity of Illness Index; Viral Vaccines	2020
A comprehensive review on sarilumab in COVID-19. Expert opinion on biological therapy, 2021, Volume: 21, Issue:5 Topics: Adenosine Monophosphate; Alanine; Animals; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Pandemics; SARS-CoV-2	2021
[Pharmacovigilance update]. Revue medicale suisse, 2021, Jan-13, Volume: 17, Issue:720-1 Topics: Adenosine Monophosphate; Alanine; Cleft Lip; Contraindications, Drug; COVID-19 Drug Treatment; Cytokine Release Syndrome; Female; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Leiomyoma; Norpregnadienes; Pharmacokinetics; Pharmacovigilance; Pregnancy; Ranitidine; Safety-Based Drug Withdrawals; Skin Neoplasms	2021
A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for the current COVID-19 (SARS-CoV-2) pandemic. Journal of medical virology, 2021, Volume: 93, Issue:5 Topics: Adenosine Monophosphate; Alanine; Amides; Antiviral Agents; Chloroquine; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Databases, Factual; Humans; Hydroxychloroquine; Immunoglobulins; Lopinavir; Pandemics; Pyrazines; Respiration, Artificial; Ritonavir; SARS-CoV-2	2021

Trials

1 trial(s) available for adenosine monophosphate and Cytokine Release Syndrome

Article	Year
Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome. The Journal of clinical investigation, 2022, 02-01, Volume: 132, Issue:3 Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Alanine; Antibodies, Monoclonal; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Disease-Free Survival; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Survival Rate; Tumor Necrosis Factor Ligand Superfamily Member 14	2022

Article

Year

Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome.

The Journal of clinical investigation, 2022, 02-01, Volume: 132, Issue:3

Topics: Adenosine Monophosphate; Adrenal Cortex Hormones; Adult; Alanine; Antibodies, Monoclonal; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Disease-Free Survival; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Survival Rate; Tumor Necrosis Factor Ligand Superfamily Member 14

2022

Other Studies

5 other study(ies) available for adenosine monophosphate and Cytokine Release Syndrome

Article	Year
Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection. Molecular biology reports, 2022, Volume: 49, Issue:1 Topics: Adenosine Monophosphate; Adult; Alanine; Antiviral Agents; Azetidines; COVID-19 Drug Treatment; Cytokine Release Syndrome; Drug Combinations; Humans; Immunologic Factors; Pandemics; Purines; Pyrazoles; Sulfonamides	2022
Impact of cytokine storm on severity of COVID-19 disease in a private hospital in West Jakarta prior to vaccination. PloS one, 2022, Volume: 17, Issue:1 Topics: Adenosine Monophosphate; Adult; Aged; Alanine; Anti-Bacterial Agents; Antibodies, Monoclonal, Humanized; Comorbidity; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Female; Hospitals, Private; Humans; Immunization, Passive; Indonesia; Male; Middle Aged; Vaccination; Vitamins	2022
Remdesivir and tocilizumab: Mix or match. Journal of medical virology, 2021, Volume: 93, Issue:1 Topics: Adenosine Monophosphate; Alanine; Antibodies, Monoclonal, Humanized; COVID-19 Drug Treatment; Cytokine Release Syndrome; Humans; Receptors, Interleukin-6; SARS-CoV-2	2021
Successful treatment with Remdesivir and corticosteroids in a patient with COVID-19-associated pneumonia: A case report. Medwave, 2020, Aug-19, Volume: 20, Issue:7 Topics: Adenosine Monophosphate; Alanine; Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Glucocorticoids; Humans; Male; Methylprednisolone; Middle Aged; Pandemics; Pneumonia, Viral; SARS-CoV-2	2020
Notes From the Field: The Combined Effects of Tocilizumab and Remdesivir in a Patient With Severe COVID-19 and Cytokine Release Syndrome. JMIR public health and surveillance, 2021, 05-19, Volume: 7, Issue:5 Topics: Adenosine Monophosphate; Aged; Alanine; Antibodies, Monoclonal, Humanized; Antiviral Agents; COVID-19; COVID-19 Drug Treatment; COVID-19 Serotherapy; Cytokine Release Syndrome; Drug Therapy, Combination; Humans; Immunization, Passive; Male; SARS-CoV-2	2021